Pharmacologic inhibition of IRAK-1 and -4 induces selective apoptosis of MDS CD34+ stem cells through a TRAF6/NF-κB-dependent mechanism without affecting normal stem cells [34]. The gene discussed is NFKB1; the disease is myelodysplastic syndrome.